CClinicalTrials.gg
CompletedNCT04376086Updated May 7, 2021

Segmental Epidural Block for Feeding Jeujunostomy in Cancer Patients

An interventional study of Epidural anesthesia and general anesthesia in Anesthesia, sponsored by National Cancer Institute, Egypt. Completed at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-05-07.

Sponsored by National Cancer Institute, Egypt · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Jun 2019, registered Apr 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study aim is to compare the efficiency and safety of segmental epidural block versus general anesthesia in cancer patients undergoing surgical feeding jejunostomy

Read the detailed description

Comparing general anesthesia versus segmental epidural anesthesia in feeding jejunostomy

02

Conditions studied

  • Anesthesia
03

In context

Lead sponsor

National Cancer Institute, Egypt is the lead sponsor of 133 studies on the registry; 29 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • patients scheduled for surgical feeding jejunostomy more than 18 years old

Exclusion criteria

Exclusion Criteria:

  • patien refusal Coagulation defect Abnormal kidney or liver functions Local infection at site of block Bone metastases
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
44 participants (actual)

Study arms

  • Active comparator
    General anesthesia

    Patients will receive general anesthesia

    Procedure: general anesthesia

  • Experimental
    Epidural anesthesia

    Patients will receive epidural anesthesia

    Procedure: Epidural anesthesia

Interventions

  • ProcedureEpidural anesthesia

    Segmental epidural analgesia

  • Proceduregeneral anesthesia

    general anesthesia

06

What researchers measure

Primary outcomes

  1. Analgesic requirements

    Analgesic requirments

    Time frame: first 24 hours

  2. Haemodynamics

    blood pressure

    Time frame: periooperative time

Secondary outcomes

  1. VAS score

    visual analouge scale 0 minimum to 10 maximum score

    Time frame: 24 hours

07

Study locations

1 site
  • National Cancer Institute
    Cairo, 11796, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 7, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04376086
Lead sponsor
National Cancer Institute, Egypt
Responsible party
Walaa Youssef Elsabeeny (Lecturer of anesthesia and pain management, National Cancer Institute, Egypt) — Principal investigator
First posted
May 6, 2020
Start date
Jun 10, 2019
Primary completion
Apr 25, 2021
Completion
Apr 26, 2021
Last update
May 7, 2021

Study contacts

Walaa Y Elsabeeny, MD
principal investigator · Lecturer

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion